FR2431863A1 - Nouveau medicament a base de vitamine a, de vitamines b, de soufre et de substances biologiques - Google Patents

Nouveau medicament a base de vitamine a, de vitamines b, de soufre et de substances biologiques

Info

Publication number
FR2431863A1
FR2431863A1 FR7821851A FR7821851A FR2431863A1 FR 2431863 A1 FR2431863 A1 FR 2431863A1 FR 7821851 A FR7821851 A FR 7821851A FR 7821851 A FR7821851 A FR 7821851A FR 2431863 A1 FR2431863 A1 FR 2431863A1
Authority
FR
France
Prior art keywords
sulphur
vitamin
complex
seborrhoea
eczema
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7821851A
Other languages
English (en)
Other versions
FR2431863B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR7821851A priority Critical patent/FR2431863A1/fr
Publication of FR2431863A1 publication Critical patent/FR2431863A1/fr
Application granted granted Critical
Publication of FR2431863B1 publication Critical patent/FR2431863B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Médicament constitué par une association. Il contient de la vitamine A, des vitamines B, du soufre et des substances biologiques. Application en dermatologie, ORL et rhumatologie.
FR7821851A 1978-07-24 1978-07-24 Nouveau medicament a base de vitamine a, de vitamines b, de soufre et de substances biologiques Granted FR2431863A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7821851A FR2431863A1 (fr) 1978-07-24 1978-07-24 Nouveau medicament a base de vitamine a, de vitamines b, de soufre et de substances biologiques

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7821851A FR2431863A1 (fr) 1978-07-24 1978-07-24 Nouveau medicament a base de vitamine a, de vitamines b, de soufre et de substances biologiques

Publications (2)

Publication Number Publication Date
FR2431863A1 true FR2431863A1 (fr) 1980-02-22
FR2431863B1 FR2431863B1 (fr) 1981-05-29

Family

ID=9211088

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7821851A Granted FR2431863A1 (fr) 1978-07-24 1978-07-24 Nouveau medicament a base de vitamine a, de vitamines b, de soufre et de substances biologiques

Country Status (1)

Country Link
FR (1) FR2431863A1 (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0138262A2 (fr) * 1983-09-26 1985-04-24 Chemisch Adviesbureau Drs. J.C.P. Schreuder B.V. Composition pour le traitement des affections de la peau et son usage
FR2647784A1 (fr) * 1989-06-06 1990-12-07 Grimberg Georges Association de vitamine a a dose physiologique et de differents principes actifs ayant une activite therapeutique
US5006338A (en) * 1987-02-18 1991-04-09 Brigitte Luenemann Wart treatment
FR2700695A1 (fr) * 1993-01-28 1994-07-29 Grimberg Georges Serge Composition thérapeutique nouvelle remédiant aux désordres survenant dans la sphère ORL.
EP0615757A1 (fr) * 1993-03-18 1994-09-21 Georges Serge Grimberg Composition thérapeutique nouvelle ayant un effet immunostimulant

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0138262A2 (fr) * 1983-09-26 1985-04-24 Chemisch Adviesbureau Drs. J.C.P. Schreuder B.V. Composition pour le traitement des affections de la peau et son usage
EP0138262A3 (en) * 1983-09-26 1987-04-22 Schreuder J C P Chem Adviesb Composition for treatment of skin affections and its application
US5006338A (en) * 1987-02-18 1991-04-09 Brigitte Luenemann Wart treatment
FR2647784A1 (fr) * 1989-06-06 1990-12-07 Grimberg Georges Association de vitamine a a dose physiologique et de differents principes actifs ayant une activite therapeutique
EP0402208A1 (fr) * 1989-06-06 1990-12-12 Georges Serge Grimberg Association de vitamine A à dose physiologique et de différents principes actifs ayant une activité thérapeutique
FR2700695A1 (fr) * 1993-01-28 1994-07-29 Grimberg Georges Serge Composition thérapeutique nouvelle remédiant aux désordres survenant dans la sphère ORL.
EP0608648A1 (fr) * 1993-01-28 1994-08-03 Georges Serge Grimberg Composition contenant une très forte quantité de vitamines A pour une dose
US5510111A (en) * 1993-01-28 1996-04-23 Grimberg; Georges S. Therapeutic composition remedying the disorders appearing in the otolaryngological sphere
EP0615757A1 (fr) * 1993-03-18 1994-09-21 Georges Serge Grimberg Composition thérapeutique nouvelle ayant un effet immunostimulant
FR2702655A1 (fr) * 1993-03-18 1994-09-23 Grimberg Georges Serge Composition thérapeutique nouvelle ayant un effet immunostimulant.

Also Published As

Publication number Publication date
FR2431863B1 (fr) 1981-05-29

Similar Documents

Publication Publication Date Title
US6191121B1 (en) Treatment of skin damage using polyenylphosphatidylcholine
MX168000B (es) Complemento dietetico que contiene beta-glucan complemento
WO2002067988A3 (fr) Utilisation d'inhibiteurs naturels de egfr permettant d'empecher les effets secondaires induits par un traitement par retinoides, des savons, et autres stimuli qui activent le recepteur du facteur de croissance epidermique
KR880009662A (ko) Igf-ii함유 약제
KR930000664A (ko) 천연 또는 합성 글리세롤 오일
EP0152106B1 (fr) Antirhumatismaux
JPS5548356A (en) Drug added animal feedstuff based on liver powder
FI862609A (fi) Akne motverkande produkt.
FR2703247B1 (fr) Emulsion a base de dihydroxyacetone et son utilisation en cosmetique.
FR2431863A1 (fr) Nouveau medicament a base de vitamine a, de vitamines b, de soufre et de substances biologiques
WO1987000432A3 (fr) Compositions contenant de la melatonine ou ses homologues, leurs utilisations pour le traitement du psoriasis vulgaris et/ou des affections apparentees
ES2137125B1 (es) La utilizacion de la sal de zinc del acido glicirretico en preparados contra el acne y las composiciones que contienen dicha sal.
ATE69550T1 (de) Salicylsaeurehaltiges mittel gegen schuppende hauterkrankungen.
JPS5251033A (en) Cosmetics
GB2210789A (en) Topical application for skin care
IE44598L (en) Coccidiocidal compositions
GB1489133A (en) Cosmetic compositions
US20120276174A1 (en) Therapeutic Treatment of Dermatologic Skin Disorders
ATE24111T1 (de) Mischung mit gehalt an einem zentral-analgetikum und an vitamine b12 oder einem seiner analoge als wirkstoffe.
KR20210009526A (ko) 복합 히아루론산을 함유하는 화장료용 조성물
Stone Pyridoxine deficiency and antagonism produce increased ground substance viscosity with resulting seborrheic dermatitis and increased tumor resistance
DE69129232D1 (de) Zusammensetzung aus asphodelus zur erhöhung der anzahl weisser blutzellen
IE34883L (en) Treatment of marek's disease with ureidodiphenyl sulfone
JPS53145927A (en) Emulsion for hair treatment
TH55310C3 (th) องค์ประกอบที่ใช้รักษาผิวหนัง

Legal Events

Date Code Title Description
CL Concession to grant licences
CL Concession to grant licences
ST Notification of lapse
ST Notification of lapse
ST Notification of lapse